INJECTABLE BONE GRAFT AND ALLOGRAFT BONE CHIPS IN THE TREATMENT OF BENIGN BONE LESION
- Head of Orthopaedic Oncology and Reconstructive Surgeon, Prince Sultan Military Medical Center, Riyadh, Saudi Arabia.
- Orthopaedic Resident, Security Force Hospital, Riyadh, Saudi Arabia.
- Orthopaedic Resident, Security Force Hospital, Riyadh, Saudi Arabia.
- Orthopaedic Resident, King Saud Medical City, Riyadh, Saudi Arabia.
- Medical Student, Alfaisal University, Riyadh, Saudi Arabia.
- Department of Orthopaedics, Orthopaedic Oncology and Adult Reconstructive Surgery, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Abstract
This study aimed to compare the efficacy of injectable bone grafts and allograft bone chips in the treatment of benign bone lesions. A total of 34 patients were included, with varying types and locations of lesions. The results showed no significant differences between the two groups in terms of age, gender, lesions type, diagnosis, site of the lesion, and bone leakage. However, the remodelling time was significantly shorter in the injectables group (5+3 months) than in the bone chips group (12+5 months). This study contributes to the understanding of the benefits and limitations of different bone grafting techniques for the treatment of benign bone lesions.
Article Analytics
How to Cite This Article
Abdulrahman Hisham Bobseit, Turki Bandar Alotaibi, Muteb Saad Alqhtani, Faisal Eid Nazal Alanazi, Abdulhadi Jameel Alotaibi and Abdullah A. Alhamdan (2023); INJECTABLE BONE GRAFT AND ALLOGRAFT BONE CHIPS IN THE TREATMENT OF BENIGN BONE LESION, Int. J. of Adv. Res., 11 (07), 1001-1008, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/17309
Corresponding Author
This work is licensed under a Creative Commons Attribution 4.0 International License.